In one of your older comments, i remember you saying.....and this isn't verbatim as id have to go find it....but something along the lines of "if they truly did submit a 510k, that would require allot of cash that they dont have". So, i don't necessarily think this is a bad thing. The total for those loans are 151k. The average cost to submit a 510k with clinical data is something like $120k isn't it? (google researching) Not saying this is exactly how it was/is used, as i have no idea, but as i said....i don't exactly see additional funding as a bad thing. Especially knowing the potential success of their new product.
News 
Market Data 
Discover 
